Wenker EP, Dupree JM, Langille GM, Kovac J, Ramasamy R, Lamb D, et al
In a May 2026 analysis, Polsinelli attorneys wrote that FDAs procedural removal of certain peptide nominations from Category 2 should not be interpreted as a green light to compound, because FDA has not necessarily moved the peptides into Category 1 or stated it will exercise enforcement discretion (National Law Review)
Sterility In true laboratory science, Sterility cannot be isolated
The primary endpoints that track response to MOTS-c therapy align with the peptide's core mechanisms: insulin sensitivity, mitochondrial function, body composition, and inflammatory tone
What we can tell you is where ours come from: regulated US peptide manufacturers and distributors, with a certificate of analysis on every batch confirming identity, purity, and concentration